A real world retrospective,cohort study to evaluate the pharmacokinetics and prophylactic effect on primary invasive fungal infection of Posaconazole (extended release) tablet in patients with Haematologic malignancies.

Trial Profile

A real world retrospective,cohort study to evaluate the pharmacokinetics and prophylactic effect on primary invasive fungal infection of Posaconazole (extended release) tablet in patients with Haematologic malignancies.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2016

At a glance

  • Drugs Posaconazole (Primary)
  • Indications Mycoses
  • Focus Pharmacokinetics
  • Most Recent Events

    • 05 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top